197 related articles for article (PubMed ID: 30165040)
1. Solution structure of SHIP2 SH2 domain and its interaction with a phosphotyrosine peptide from c-MET.
Wang Z; Nie Y; Zhang K; Xu H; Ramelot TA; Kennedy MA; Liu M; Zhu J; Yang Y
Arch Biochem Biophys; 2018 Oct; 656():31-37. PubMed ID: 30165040
[TBL] [Abstract][Full Text] [Related]
2. An auxiliary binding interface of SHIP2-SH2 for Y292-phosphorylated FcγRIIB reveals diverse recognition mechanisms for tyrosine-phosphorylated receptors involved in different cell signaling pathways.
Wang Z; Zhou H; Yue X; Zhu J; Yang Y; Liu M
Anal Bioanal Chem; 2022 Jan; 414(1):497-506. PubMed ID: 34021368
[TBL] [Abstract][Full Text] [Related]
3. Structural Insights into the Binding Propensity of Human SHIP2 SH2 to Oncogenic CagA Isoforms from
Wang Z; Shan Y; Wang R; Zhou H; Hu R; Li Y; Zhu J; Yang Y; Liu M
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232599
[TBL] [Abstract][Full Text] [Related]
4. The SH2 domains of inositol polyphosphate 5-phosphatases SHIP1 and SHIP2 have similar ligand specificity but different binding kinetics.
Zhang Y; Wavreille AS; Kunys AR; Pei D
Biochemistry; 2009 Nov; 48(46):11075-83. PubMed ID: 19839650
[TBL] [Abstract][Full Text] [Related]
5. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
Lubman OY; Waksman G
J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339
[TBL] [Abstract][Full Text] [Related]
6. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
[TBL] [Abstract][Full Text] [Related]
7. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.
Eck MJ; Shoelson SE; Harrison SC
Nature; 1993 Mar; 362(6415):87-91. PubMed ID: 7680435
[TBL] [Abstract][Full Text] [Related]
8. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains.
Chalupny NJ; Aruffo A; Esselstyn JM; Chan PY; Bajorath J; Blake J; Gilliland LK; Ledbetter JA; Tepper MA
Eur J Immunol; 1995 Oct; 25(10):2978-84. PubMed ID: 7589101
[TBL] [Abstract][Full Text] [Related]
9. Role of electrostatic interactions in SH2 domain recognition: salt-dependence of tyrosyl-phosphorylated peptide binding to the tandem SH2 domain of the Syk kinase and the single SH2 domain of the Src kinase.
Grucza RA; Bradshaw JM; Mitaxov V; Waksman G
Biochemistry; 2000 Aug; 39(33):10072-81. PubMed ID: 10955995
[TBL] [Abstract][Full Text] [Related]
10. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
Bradshaw JM; Mitaxov V; Waksman G
J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978
[TBL] [Abstract][Full Text] [Related]
11. Mutational investigation of the specificity determining region of the Src SH2 domain.
Bradshaw JM; Mitaxov V; Waksman G
J Mol Biol; 2000 Jun; 299(2):521-35. PubMed ID: 10860756
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning of rat SH2-containing inositol phosphatase 2 (SHIP2) and its role in the regulation of insulin signaling.
Ishihara H; Sasaoka T; Hori H; Wada T; Hirai H; Haruta T; Langlois WJ; Kobayashi M
Biochem Biophys Res Commun; 1999 Jun; 260(1):265-72. PubMed ID: 10381377
[TBL] [Abstract][Full Text] [Related]
13. The SH2 domain containing inositol 5-phosphatase SHIP2 associates to the immunoreceptor tyrosine-based inhibition motif of Fc gammaRIIB in B cells under negative signaling.
Muraille E; Bruhns P; Pesesse X; Daëron M; Erneux C
Immunol Lett; 2000 Apr; 72(1):7-15. PubMed ID: 10789675
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of the C-terminal SH2 domain of the p85alpha regulatory subunit of phosphoinositide 3-kinase: an SH2 domain mimicking its own substrate.
Hoedemaeker FJ; Siegal G; Roe SM; Driscoll PC; Abrahams JP
J Mol Biol; 1999 Oct; 292(4):763-70. PubMed ID: 10525402
[TBL] [Abstract][Full Text] [Related]
15. Six X-linked agammaglobulinemia-causing missense mutations in the Src homology 2 domain of Bruton's tyrosine kinase: phosphotyrosine-binding and circular dichroism analysis.
Mattsson PT; Lappalainen I; Bäckesjö CM; Brockmann E; Laurén S; Vihinen M; Smith CI
J Immunol; 2000 Apr; 164(8):4170-7. PubMed ID: 10754312
[TBL] [Abstract][Full Text] [Related]
16. Stability and peptide binding specificity of Btk SH2 domain: molecular basis for X-linked agammaglobulinemia.
Tzeng SR; Pai MT; Lung FD; Wu CW; Roller PP; Lei B; Wei CJ; Tu SC; Chen SH; Soong WJ; Cheng JW
Protein Sci; 2000 Dec; 9(12):2377-85. PubMed ID: 11206059
[TBL] [Abstract][Full Text] [Related]
17. Solution structure of the C-terminal SH2 domain of the human tyrosine kinase Syk complexed with a phosphotyrosine pentapeptide.
Narula SS; Yuan RW; Adams SE; Green OM; Green J; Philips TB; Zydowsky LD; Botfield MC; Hatada M; Laird ER
Structure; 1995 Oct; 3(10):1061-73. PubMed ID: 8590001
[TBL] [Abstract][Full Text] [Related]
18. Membrane localization of Src homology 2-containing inositol 5'-phosphatase 2 via Shc association is required for the negative regulation of insulin signaling in Rat1 fibroblasts overexpressing insulin receptors.
Ishihara H; Sasaoka T; Ishiki M; Wada T; Hori H; Kagawa S; Kobayashi M
Mol Endocrinol; 2002 Oct; 16(10):2371-81. PubMed ID: 12351701
[TBL] [Abstract][Full Text] [Related]
19. Specific tyrosine phosphorylations mediate signal-dependent stimulation of SHIP2 inositol phosphatase activity, while the SH2 domain confers an inhibitory effect to maintain the basal activity.
Prasad NK; Werner ME; Decker SJ
Biochemistry; 2009 Jul; 48(27):6285-7. PubMed ID: 19518129
[TBL] [Abstract][Full Text] [Related]
20. Expression, purification and characterization of the RhoA-binding domain of human SHIP2 in E.coli.
Zhou H; Yue X; Wang Z; Li S; Zhu J; Yang Y; Liu M
Protein Expr Purif; 2021 Apr; 180():105821. PubMed ID: 33421554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
